US scientists have successfully created the first new vaccine against Ebola virus, announced Thursday.
A group of scientists headed by Dr. Francis Collins and Dr. Anthony Fauci developed the Ebola vaccine at the National Institutes of Health.
Ebola virus which first appeared in West Africa has killed almost 6,000 people infecting 16,000 persons worldwide. Liberia, Guinea and Sierra Leone have the highest cases of Ebola virus with 15, 901 cases and 5, 674 deaths being recorded since the beginning of the outbreak.
The first human trial of the vaccine against Ebola virus showed an initial positive result to prevent the spread of the virus. The new vaccine is made by British drugs giant GlaxoSmithKline which uses a chimpanzee cold virus and has been genetically engineered to carry a non- infectious Ebola protein on its surface. GSK teaches the body to recognize the virus preparing the immune system to fight in case of an infection. By the end of 2015, GSK commits to produce one million doses a month.
On the other hand, 20 US volunteers participated in the experimental treatment vaccine and it revealed that results caused no serious side effects. The vaccine was given through intramuscular injection at a lower dose in the first group while the second group received higher dose. Both tests produced promising results.
“Based on these positive results from the first human trial of this candidate, we are continuing our accelerated plan for larger trials to determine if the vaccine is efficacious in preventing Ebola infection,” Dr. Fauci stated.